Although the actions of VEGF-C/VEGFR-3 have been studied extensively in the lymphatic system [13], [14], VEGF-C and VEGFR-3 are also expressed in glioblastomas and hemangioblastomas that are devoid of lymphatic vessels [15]. Here, FLT4 is linked to hemangioblastoma.